CAR-T therapy is an incredibly powerful and relatively new form of cancer treatment through synthetic biology. As these treatments begin to win Food and Drug Administration (FDA) safety approval, the need for oversight and ethical debate continues to grow. Ethical concerns cover both human research subjects and patients undergoing cancer treatments with these new therapies. CAR-T therapy was once considered a “last resort” effort in cancer treatment, but is now becoming more mainstream due to the extreme effectiveness of some treatments. Ethical concerns include both equitable distribution of treatment along financial and geographic lines, and managing patient expectations of ...Read more
